切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2023, Vol. 17 ›› Issue (02) : 148 -150. doi: 10.3877/cma.j.issn.1674-0793.2023.02.015

综述

长链非编码RNA HOTAIR在肝细胞癌中的研究进展
薛见进1, 周嘉嘉1,()   
  1. 1. 510120 广州,中山大学孙逸仙纪念医院小儿外科
  • 收稿日期:2022-08-12 出版日期:2023-04-01
  • 通信作者: 周嘉嘉
  • 基金资助:
    国家自然科学基金项目(82073062); 广东省自然科学基金项目(2018A030313624)

Advances of lncRNA HOTAIR in hepatocellular carcinoma progression

Jianjin Xue1, Jiajia Zhou1,()   

  1. 1. Department of Pediatric Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
  • Received:2022-08-12 Published:2023-04-01
  • Corresponding author: Jiajia Zhou
引用本文:

薛见进, 周嘉嘉. 长链非编码RNA HOTAIR在肝细胞癌中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2023, 17(02): 148-150.

Jianjin Xue, Jiajia Zhou. Advances of lncRNA HOTAIR in hepatocellular carcinoma progression[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(02): 148-150.

肝细胞癌是一种常见的肝脏恶性肿瘤,具拥有较高的死亡率。HOX转录反义RNA(HOTAIR)作为被发现的第一个具有反式作用的lncRNA,已被证实在肝癌等多种肿瘤发生、发展中发挥关键调控作用。本文在对HOTAIR概述的基础上,重点对HOTAIR在肝细胞癌中的表达以及对疾病发生、增殖、转移、耐药性和糖代谢等方面的调控作用进行综述。

Hepatocellular carcinoma (HCC) is a common liver malignant tumor with high mortality. HOX transcriptional antisense RNA (HOTAIR), the first identified long non-coding RNA (lncRNA) with a trans role, has been shown to play a key regulatory role in the development and progression of various tumors, including HCC. Based on the overview of HOTAIR, this article focuses on the expression of HOTAIR in HCC and its regulatory role in the carcinogenesis, proliferation, metastasis, drug resistance and glucose metabolism of HCC.

[1]
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2]
Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60 770 full-length cDNAs[J]. Nature, 2002, 420(6915): 563-573.
[3]
Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs[J]. Cell, 2007, 129(7): 1311-1323.
[4]
He S, Liu S, Zhu H. The sequence, structure and evolutionary features of HOTAIR in mammals[J]. BMC Evol Biol, 2011, 11: 102.
[5]
Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes[J]. Science, 2010, 329(5992): 689-693.
[6]
Hayami S, Kelly JD, Cho HS, et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers[J]. Int J Cancer, 2011, 128(3): 574-586.
[7]
Fan L, Lei H, Lin Y, et al. Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis[J]. Cell Mol Life Sci, 2022, 79(5): 254.
[8]
Zhang J, Qiu WQ, Zhu H, et al. HOTAIR contributes to the carcinogenesis of gastric cancer via modulating cellular and exosomal miRNAs level[J]. Cell Death Dis, 2020, 11(9): 780.
[9]
Zhong DN, Luo YH, Mo WJ, et al. High expression of long non-coding HOTAIR correlated with hepatocarcinogenesis and metastasis[J]. Mol Med Rep, 2018, 17(1): 1148-1156.
[10]
Han C, Yang Y, Guo L, et al. The expression of long non-coding RNA HOTAIR in advanced hepatocellular carcinoma and its prognostic correlation with sunitinib therapy[J]. Arch Med Sci, 2022, 18(1): 71-78.
[11]
Yang L, Peng X, Li Y, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1): 78.
[12]
Fu WM, Zhu X, Wang WM, et al. Hotair mediates hepatocarc-inogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling[J]. J Hepatol, 2015, 63(4): 886-895.
[13]
Cheng D, Deng J, Zhang B, et al. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation[J]. EBioMedicine, 2018, 36: 159-170.
[14]
Liu C, Shang Z, Ma Y, et al. HOTAIR/miR-214-3p/FLOT1 axis plays an essential role in the proliferation, migration, and invasion of hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2019, 12(1): 50-63.
[15]
Wu Y, Xiong Q, Li S, et al. Integrated proteomic and transcriptomic analysis reveals long noncoding RNA HOX transcript antisense intergenic RNA (HOTAIR) promotes hepatocellular carcinoma cell proliferation by regulating opioid growth factor receptor (OGFr)[J]. Mol Cell Proteomics, 2018, 17(1): 146-159.
[16]
Topel H, Bagirsakci E, Comez D, et al. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells[J]. Cell Commun Signal, 2020, 18(1): 110.
[17]
Ding C, Cheng S, Yang Z, et al. Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells[J]. Int J Mol Sci, 2014, 15(3): 4060-4076.
[18]
Tang X, Zhang W, Ye Y, et al. LncRNA HOTAIR contributes to sorafenib resistance through suppressing miR-217 in hepatic carcinoma[J]. Biomed Res Int, 2020, 2020: 9515071.
[19]
Wei S, Fan Q, Yang L, et al. Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling[J]. Oncol Rep, 2017, 38(3): 1902-1908.
[20]
Hu M, Fu Q, Jing C, et al. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia[J]. Biomed Pharmacother, 2020, 125: 109703.
[1] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[6] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[7] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[8] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[11] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[12] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[13] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[14] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[15] 张杰, 田广磊, 陈雄. 基于生物信息学分析探讨肝癌BRD4与预后关系及其ceRNA调控网络构建[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 568-576.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?